Henry Klingenstein is a frontier technology investor primarily focused on healthcare, fintech, and consumer. Prior to ARTIS, Henry incubated Spur Labs, a computational medicine startup building diagnostics with ML, as a researcher in Sendhil Mullainathan’s lab at the University of Chicago. Earlier in his career he worked at ARTIS portfolio company Quid, an AI market intelligence company, where he focused on healthcare and industrial applications of the technology. He also spent time as a fellow at Longitude Capital. Henry holds an MBA from the Stanford Graduate School of Business and an AB from Harvard College.

‍

Investments & Boards

Eko, ‍Ozlo Sleep, Climax Foods, ONI, Mytos, FIG, Glyphic, Locus